Psoriasis is a chronic autoimmune skin disorder characterized by inflammation that manifests as itchy, painful plaques and scales on the skin. It affects an estimated 125 million people worldwide. One in three develop psoriatic arthritis, which can lead to joint pain and stiffness and permanent joint damage. Patients with psoriasis are at greater risk of developing other conditions, such as obesity, diabetes, cardiovascular disease, and depression.

At Oruka, we are advancing a new era of biologics with the potential to enable higher rates of complete skin clearance, durable remissions, and more convenient dosing regimens for patients around the globe.